F10 and COVID-19: Heparin therapy is widely recommended in patients with COVID-19. Considering that it acts as the cofactor for ATIII to inhibit thrombin and factor Xa, an investigation on the impact of heparin therapy on thrombin time (TT) and factor Xa activity may be an interesting theme for further research.